|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: micronized oral progesteroneFrom: Bernard Cristalli (bclaure@mailhost.grolier.fr)Mon Dec 30 14:15:12 1996
dahmd@gate.net wrote: > > Dear colleagues- > > A number of patients are approaching me about using micronized oral > progesterone (MP) instead of using medroxyprogesterone acetate (MPA, usually > marketed as "Provera" in the U.S.). I have seen a few studies, including the > PEPI trial, that support the use of MP over MPA. My take on the literature > is that 100mg each day of the month as part of a continuous hormone > replacement regimen, or 300mg/day for 10 days a month as part of a cyclic > regimen, will result in atrophic endometria. (Others have suggested that there > is not enough literature yet, and patients on MP should undergo an annual > endometrial biospy to rule out hyperplasia/cancer). I also understand that > taking this with food increases the bioavailability. > > Any pearls of wisdom from list members who use MP regularly? Many thanks in > advance. > > Ashley > D. Ashley Hill, M.D. > dahmd@gate.net > Orlando, FL Hi, Here you will have a few references…
-- Bernard Cristalli MD CNGOF Paris - France
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:20:21 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.